Immuneering (IMRX) Non-Current Assets (2020 - 2024)
Historic Non-Current Assets for Immuneering (IMRX) over the last 5 years, with Q3 2024 value amounting to $13.3 million.
- Immuneering's Non-Current Assets changed 0.43% to $13.3 million in Q3 2024 from the same period last year, while for Sep 2024 it was $53.7 million, marking a year-over-year decrease of 6.39%. This contributed to the annual value of $13.5 million for FY2023, which is 87.81% down from last year.
- As of Q3 2024, Immuneering's Non-Current Assets stood at $13.3 million, which was down 0.43% from $13.4 million recorded in Q2 2024.
- Over the past 5 years, Immuneering's Non-Current Assets peaked at $14.4 million during Q4 2021, and registered a low of $691799.0 during Q4 2020.
- Moreover, its 5-year median value for Non-Current Assets was $13.4 million (2023), whereas its average is $11.6 million.
- Per our database at Business Quant, Immuneering's Non-Current Assets skyrocketed by 197731.38% in 2021 and then plummeted by 522.14% in 2022.
- Immuneering's Non-Current Assets (Quarter) stood at $691799.0 in 2020, then soared by 1977.31% to $14.4 million in 2021, then decreased by 5.22% to $13.6 million in 2022, then dropped by 0.88% to $13.5 million in 2023, then dropped by 1.51% to $13.3 million in 2024.
- Its Non-Current Assets was $13.3 million in Q3 2024, compared to $13.4 million in Q2 2024 and $13.5 million in Q1 2024.